发明名称 |
Compositions and methods for glycemic control of subjects with impaired fasting glucose |
摘要 |
Compositions and methods for providing anti-diabetic and anti-hyperlipidemia benefits to diabetic subjects currently on medication but not meeting recommended targets for blood glucose, HbA1c, blood pressure and total cholesterol. |
申请公布号 |
US9610276(B2) |
申请公布日期 |
2017.04.04 |
申请号 |
US201514812256 |
申请日期 |
2015.07.29 |
申请人 |
KGK Synergize, Inc. |
发明人 |
Guthrie Najla |
分类号 |
A61K31/355;A61K31/352;A61K31/353;A61K38/16;A61K45/06;A61K31/155;A61K31/366 |
主分类号 |
A61K31/355 |
代理机构 |
Porzio, Bromberg & Newman P.C. |
代理人 |
Porzio, Bromberg & Newman P.C. |
主权项 |
1. A method comprising administering an effective amount of a composition to a subject diagnosed with diabetes, wherein the subject is currently taking one or more prescribed medications for control of diabetes, wherein the one or more prescribed medications are selected from the group consisting of: metformin, acarbose, fibrates, thiazolidienodiones, Sulphonylureas, and combinations thereof, wherein the subject does not have the following: HbA1c≦7%; LDL-C≦100 mg/dL; total cholesterol≦200 mg/dL; and systolic blood pressure≦130 mmHg, wherein after a predetermined period of supplementation with the composition, the subject has at least one of the following: HbA1c≦7%; LDL-C≦100 mg/dL; total cholesterol≦200 mg/dL; and systolic blood pressure≦130 mmHg; and
wherein the composition comprises at least one polymethoxyflavone. |
地址 |
London CA |